Galectin Therapeutics Inc. (GALT)

[Tesla1]

TFM: My two cents is that the PRs are written for industry and not for individual investors. At this stage in the game (successful phase 1 trial with efficacy demonstrated) for a potential blockbuster new drug, partnering with large pharma would be the norm (in my opinion.) I don't have a crystal ball but I would be surprised if there is not a deal (at some point) during the next 6-12 months (money upfront, annual amounts, completion amounts/FDA approval and royalties based on revenues). All IMHO